563 results on '"Kawaoka, Yoshihiro"'
Search Results
2. Highly pathogenic H5N1 avian influenza virus outbreak in cattle: the knowns and unknowns
3. A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters
4. Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65–85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial
5. Drug susceptibility and the potential for drug-resistant SARS-CoV-2 emergence in immunocompromised animals
6. Host range, transmissibility and antigenicity of a pangolin coronavirus
7. Defining the risk of SARS-CoV-2 variants on immune protection
8. Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses
9. Glyco-engineered MDCK cells display preferred receptors of H3N2 influenza absent in eggs used for vaccines
10. In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir
11. Antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination
12. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
13. Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2
14. Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection
15. Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization.
16. Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge
17. Tracing the origin of SARS-CoV-2 omicron-like spike sequences detected in an urban sewershed: a targeted, longitudinal surveillance study of a cryptic wastewater lineage
18. Assessment of the antigenic evolution of a clade 6B.1 human H1N1pdm influenza virus revealed differences between ferret and human convalescent sera
19. Characterization of a human H3N8 influenza virus
20. Seroprevalence of SARS-CoV-2 antibodies in dogs and cats during the early and mid-pandemic periods in Japan
21. Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate
22. Isolation of Bat Sarbecoviruses, Japan
23. Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022
24. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
25. Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination
26. Transmission and re-infection of Omicron variant XBB.1.5 in hamsters
27. Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents
28. In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters
29. High titers of infectious SARS-CoV-2 in corpses of patients with COVID-19
30. Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections
31. Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters
32. Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2
33. COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions
34. Cow’s Milk Containing Avian Influenza A(H5N1) Virus — Heat Inactivation and Infectivity in Mice
35. Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays
36. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
37. mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
38. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
39. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
40. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
41. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
42. Sialylated and sulfated N-Glycans in MDCK and engineered MDCK cells for influenza virus studies
43. A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases
44. Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
45. Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models
46. Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2
47. A compendium of multi-omics data illuminating host responses to lethal human virus infections
48. Development of a Mouse-Adapted Reporter SARS-CoV-2 as a Tool for Two-Photon In Vivo Imaging
49. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
50. Avian H6 Influenza Viruses in Vietnamese Live Bird Markets during 2018–2021
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.